Shao Y - Search Results

1

Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection.

Bao H, Wang Z, Ma X, Guo W, Zhang X, Tang W, Chen X, Wang X, Chen Y, Mo S, Liang N, Ma Q, Wu S, Xu X, Chang S, Wei Y, Zhang X, Bao H, Liu R, Yang S, Jiang Y, Wu X, Li Y, Zhang L, Tan F, Xue Q, Liu F, Cai S, Gao S, Peng J, Zhou J, Shao Y. Bao H, et al. Among authors: shao y. Mol Cancer. 2022 Jun 11;21(1):129. doi: 10.1186/s12943-022-01594-w. Mol Cancer. 2022. PMID: 35690859 Free PMC article. Clinical Trial.

2

Mutational profiling of non-small-cell lung cancer patients resistant to first-generation EGFR tyrosine kinase inhibitors using next generation sequencing.

Jin Y, Shao Y, Shi X, Lou G, Zhang Y, Wu X, Tong X, Yu X. Jin Y, et al. Among authors: shao y. Oncotarget. 2016 Sep 20;7(38):61755-61763. doi: 10.18632/oncotarget.11237. Oncotarget. 2016. PMID: 27528220 Free PMC article.

3

Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells.

Jiang BY, Li YS, Guo WB, Zhang XC, Chen ZH, Su J, Zhong WZ, Yang XN, Yang JJ, Shao Y, Huang B, Liu YH, Zhou Q, Tu HY, Chen HJ, Wang Z, Xu CR, Wang BC, Wu SY, Gao CY, Zhang X, Wu YL. Jiang BY, et al. Among authors: shao y. Clin Cancer Res. 2017 Sep 15;23(18):5480-5488. doi: 10.1158/1078-0432.CCR-17-0047. Epub 2017 Jun 12. Clin Cancer Res. 2017. PMID: 28606923

4

Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis.

Lan X, Bao H, Ge X, Cao J, Fan X, Zhang Q, Liu K, Zhang X, Tan Z, Zheng C, Wang A, Chen C, Zhu X, Wang J, Xu J, Zhu X, Wu X, Wang X, Shao Y, Ge M. Lan X, et al. Among authors: shao y. Cancer Sci. 2020 Jun;111(6):2163-2173. doi: 10.1111/cas.14389. Epub 2020 Apr 16. Cancer Sci. 2020. PMID: 32187423 Free PMC article.

5

Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M-positive Non-Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study.

Xing L, Pan Y, Shi Y, Shu Y, Feng J, Li W, Cao L, Wang L, Gu W, Song Y, Xing P, Liu Y, Gao W, Cui J, Hu N, Li R, Bao H, Shao Y, Yu J. Xing L, et al. Among authors: shao y. Clin Cancer Res. 2020 Dec 1;26(23):6168-6175. doi: 10.1158/1078-0432.CCR-20-2081. Epub 2020 Aug 17. Clin Cancer Res. 2020. PMID: 32817079

6

The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors.

Jin Y, Chen DL, Wang F, Yang CP, Chen XX, You JQ, Huang JS, Shao Y, Zhu DQ, Ouyang YM, Luo HY, Wang ZQ, Wang FH, Li YH, Xu RH, Zhang DS. Jin Y, et al. Among authors: shao y. Mol Cancer. 2020 Oct 30;19(1):154. doi: 10.1186/s12943-020-01274-7. Mol Cancer. 2020. PMID: 33126883 Free PMC article.

7

Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer.

Yang XR, Pi C, Yu R, Fan XJ, Peng XX, Zhang XC, Chen ZH, Wu X, Shao Y, Wu YL, Zhou Q. Yang XR, et al. Among authors: shao y. Clin Exp Metastasis. 2021 Feb;38(1):109-117. doi: 10.1007/s10585-020-10062-y. Epub 2020 Nov 24. Clin Exp Metastasis. 2021. PMID: 33231826 Free PMC article.

8

Acquired rare recurrent EGFR mutations as mechanisms of resistance to Osimertinib in lung cancer and in silico structural modelling.

Lin L, Lu Q, Cao R, Ou Q, Ma Y, Bao H, Wu X, Shao Y, Wang Z, Shen B. Lin L, et al. Among authors: shao y. Am J Cancer Res. 2020 Nov 1;10(11):4005-4015. eCollection 2020. Am J Cancer Res. 2020. PMID: 33294282 Free PMC article.

9

STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review.

Su C, Jiang Y, Jiang W, Wang H, Liu S, Shao Y, Zhao W, Ning R, Yu Q. Su C, et al. Among authors: shao y. Onco Targets Ther. 2020 Dec 4;13:12515-12519. doi: 10.2147/OTT.S282933. eCollection 2020. Onco Targets Ther. 2020. PMID: 33311990 Free PMC article.

10

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer.

Kang J, Zhang XC, Chen HJ, Zhong WZ, Xu Y, Su J, Zhou Q, Tu HY, Wang Z, Xu CR, Yang XN, Chen ZH, Wu X, Zhang X, Shao Y, Wu YL, Yang JJ. Kang J, et al. Among authors: shao y. Front Oncol. 2020 Dec 11;10:596937. doi: 10.3389/fonc.2020.596937. eCollection 2020. Front Oncol. 2020. PMID: 33363027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,877 results

Search Page